Ionis Pharmaceuticals | IONS - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Arrowhead Research USD 568.42M 102.37M 2025-12
Astellas Pharma JPY 1.76T 150.69B 2025-12
BioCryst Pharmaceuticals USD -119.15M 268.74M 2025-12
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Exelixis USD 2.16B 619K 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Omeros USD -228.68M 15.13M 2025-06
OPKO Health USD 1.27B 37.53M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pfizer USD 92.8B 4.11B 2025-09
Pharma Mar EUR 251.83M 54.32M 2025-12
PTC Therapeutics USD -205.31M 49.56M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tilray USD 1.58B 39.08M 2025-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09